Submit

News

Mesothelioma Awareness Day

Mesothelioma Awareness Day

The other day I was in Lowe’s looking for light bulbs and an elderly man was wearing a hat with the ship he served on just like the one my grandfather wore daily.  The emotions caught me off guard.  I will miss seeing my grandfather or ‘Old Man’ wearing a similar hat.  My grandfather served over 20

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

Press Release  FOR IMMEDIATE RELEASE ON SEPTEMBER 14, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 669-9531 cfrierson@lungcancerinitiativenc.org   10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally September 14,

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves Tomma Hargraves, lung cancer survivor and board secretary for the Lung Cancer Initiative of North Carolina, shares with us one of the many ways that she gets involved in helping others who have received a cancer diagnosis.  The Lay Patient Navigation

ASCO Update

ASCO Update

ASCO Update In June, the American Society of Clinical Oncology (ASCO) had their annual meeting in Chicago.  They are the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.  We were pleased to have Jenni Danai, our Senior Programs

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

Press Release  FOR IMMEDIATE RELEASE ON JUNE 11, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 784-0410 ext. 102 cfrierson@lungcancerinitiativenc.org   125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

Press Release  FOR IMMEDIATE RELEASE ON JUNE 28, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 784-0410 ext. 102 cfrierson@lungcancerinitiativenc.org   10,000 Grant Awarded to Improve Access to Lung Cancer Screening

2016 Online Survey

2016 Online Survey

Lung Cancer Initiative of North Carolina has been experiencing exciting growth over the last couple years, and we are committed to continuing to improve our services to the state as we grow. This summer we are excited to embark on an organizational assessment and strategic planning process as we

Lung Cancer Biosimilar Study

Lung Cancer Biosimilar Study

Lung Cancer Biosimilar Study Boehringer Ingelheim has an international clinical research study with a potential new treatment for nonsquamous non-small cell lung cancer.  Back in May during Clinical Trials Awareness Week, we mentioned the importance of taking part in clinical research and shared

Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib

Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib

Click here to read original article. Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib Comprehensive ELUXA trial program explores olmutinib (BI 1482694) as a monotherapy and in several combination studies

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non-Small Cell Lung Cancer

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non-Small Cell Lung Cancer

The original article can be found here. The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth

GuideStar Gold Participant